A CRYSTALLINE VARIABLE HYDRATE OF (S)-6-(4-(2-((3-(9H-CARBAZOL-4- YLOXY)-2-HYDROXYPROPYL)AMINO)-2-METHYLPROPYL)PHENOXY)-3- PYRIDINICARBOX AMIDE HEMISUCCINATE SALT.

摘要

The present invention relates to a crystalline variable hydrate of (S)-(3- pyridinecarboxamide, 6-[4-[2-[[3-(9H- carbazol-4-yloxy)-2-hydroxypropyl]amino]-2-methylpropyl]phenoxy]) -hemi-succinate,a pharmaceutical formulation containing said salt and to methods for treatingobesity and/or Type 2 diabetes using said salt.